Antibióticos inhalados para las exacerbaciones pulmonares de la fibrosis quística
Información
- DOI:
- https://doi.org/10.1002/14651858.CD008319.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 12 diciembre 2012see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Fibrosis quística y enfermedades genéticas
- Copyright:
-
- Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Gerard Ryan conceived the protocol and all three authors worked on drafting the protocol.
NIkki Jahnke and Tracey Remmington undertook trial selection and data extraction. Nikki Janke entered data and with Gerard Ryan drafted the first version of the review. All authors worked on finalising the review following peer reviewer comments and editorial input.
Sources of support
Internal sources
-
NIHR National Programme (Department of Health), UK.
External sources
-
No sources of support supplied
Declarations of interest
Dr Gerard Ryan has received funds for research as follows:
1. Aztreonam trial
This was a multi‐centre industry‐sponsored trial. Dr Ryan works in a CF centre that contributed participants to the trial with funding going to Lung Institute of Western Australia (LIWA) for research staff. No funding went to the CF centre.
Acknowledgements
We would like to thank the contact editor for this review, Dr Kevin Southern, and the peer reviewers for their helpful and constructive comments.
Version history
| Published | Title | Stage | Authors | Version |
| 2022 Aug 01 | Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis | Review | Sherie Smith, Nicola J Rowbotham, Edward Charbek | |
| 2018 Oct 30 | Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis | Review | Sherie Smith, Nicola J Rowbotham, Edward Charbek | |
| 2012 Dec 12 | Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis | Review | Gerard Ryan, Nikki Jahnke, Tracey Remmington | |
| 2010 Jan 20 | Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis | Protocol | Gerard Ryan, Tracey Remmington, Nikki Jahnke | |
Differences between protocol and review
Unit of analysis issues
Previously we proposed excluding all cross‐over trials from this review. However, on revisiting the issue of the inclusion of such trials, all three authors agreed that the inclusion of first‐arm data from these trials would be appropriate.
